Summary of Study ST001129
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000703. The data can be accessed directly via it's Project DOI: 10.21228/M8T10P This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001129 |
Study Title | P4HA1 knockdown in the breast cell line MDA231 (part III) |
Study Type | isotope tracer |
Study Summary | Determine the effect of knocking down P4HA1 in the MDA231 cell line (including alterations to metabolic pathways).Control versus knockdown |
Institute | University of Kentucky |
Department | Markey Cancer Center |
Last Name | Xiong |
First Name | Gaofeng |
Address | BBSRC361, 741 South Limestone, Lexington, KY 40536, USA |
gaofeng.xiong@uky.edu | |
Phone | 000-000-0000 |
Submit Date | 2019-01-30 |
Study Comments | For additional comments about the study, like listing a publication. |
Raw Data Available | Yes |
Raw Data File Type(s) | fid |
Analysis Type Detail | NMR |
Release Date | 2019-03-06 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR001215 |
Treatment Summary: | Cells grown in unlabeled glucose and infected with empty vector. Cells grown in unlabeled glucose and infected with shP4HA1 lentivirus. Cells grown in labeled glucose and infected with empty vector. Cells grown in labeled glucose and infected with shP4HA1 lentivirus. |
Treatment Protocol ID: | 12CGlc_shCTL 12CGlc_shP4HA1 13CGlc_shCTL 13CGlc_shP4HA1 |